Dr Tan Sing Huang is a Senior Consultant Medical Oncologist with over 30 years of experience in managing a wide range of cancers. Prior to joining OncoCare Cancer Centre, she was a Senior Consultant in the Department of Haematology-Oncology at the National University Cancer Institute, Singapore (NCIS), and an Assistant Professor at the Yong Loo Lin School of Medicine, National University of Singapore (NUS).
During her time at NCIS and in her current practice, she has treated patients with a variety of cancers, including breast, gynaecological (ovarian, uterine, cervical), lung, and gastrointestinal (colon, rectal, pancreatic, liver, and gastric) cancers, with a primary interest in women’s cancers such as breast cancer. In recognition of her commitment to excellent patient care, she was awarded the Sunny Side-Up and Sunny Side-Up WOW Awards.
She served as the Programme Director for the Senior Residency Programme at NCIS from 2012 to 2016. She was also Co-Chair of the NCIS Clinical Competency Committee and an examiner for undergraduate medical examinations, for which she received the NUH Teaching Excellence Award in 2014.
She was Vice President of the Singapore Society of Oncology from 2013 to 2018 and served on the National Healthcare Group Domain-Specific Ethics Review Board as Deputy Chair from 2020 to 2024.
Her research experience includes work with the RUNX research group in Singapore, as well as epigenetics research at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center from 2006 to 2007, where she also gained experience in the Breast Cancer Division. She has served as the principal investigator for multi-centre studies evaluating new investigational drugs in HER2-positive breast cancer, and as a co-investigator in clinical trials involving lung, colorectal, and breast cancers. Her research has explored methylation patterns, oncogenic mutation profiling, and chemotherapy-related cognitive effects.
She has authored chapters on metastatic breast cancer in international textbooks such as Diseases of the Breast. In addition, she has contributed to publications in both local and international journals, including Clinical Cancer Research and Annals of Oncology. She was also a member of the Singapore Cancer Network Breast
Cancer Workgroup, where she contributed to the development of local guidelines for breast cancer treatment.
She has chaired conferences and has been invited as a speaker at both local and international conferences and symposiums, including those held in China, Vietnam, and Brunei. She is fluent in English, Mandarin, and Hokkien, and can converse in Malay and Bahasa Indonesia. She has cared for patients from a wide range of regions, including Indonesia, Vietnam, Myanmar, China, Bangladesh, Sri Lanka, India, and Russia.
